An Australian drug delivery technology, developed by Monash University researchers in partnership with PureTech Health plc (Nasdaq: PRTC, LSE: PRTC), has today released results from a multipart Phase 1 trial of the prodrug ...
Dec 21, 2022
0
4
An international research team has identified "born to be bad" colorectal tumors in people with early stage cancer, which could help medical experts pinpoint and better treat aggressive tumors.
Dec 19, 2022
0
76
The world's largest trial into the effect of multiple interventions for critically ill adults with COVID-19 on longer-term outcomes has released results from the 180-day (six month) follow-up of 4,869 critically ill patients.
Dec 19, 2022
0
42
Abortion services and advice in Australia are limited despite being legal, a new study has found.
Dec 16, 2022
0
3
Older age is now the most common time to develop epilepsy in high-income settings, and an evidence review led by a Monash research team has highlighted that older adults are at risk of new-onset seizures due to age-related ...
Dec 15, 2022
0
12
People who are off work due to injury or illness are at higher risk of later suicide and intentional self-harm, a new international study by Monash University School of Public Health and Preventive Medicine researchers has ...
Dec 13, 2022
0
14
New artificial intelligence (AI) technology that detects subtle changes in the retina could prove a game-changer in helping millions of people avoid vision loss or blindness.
Dec 7, 2022
0
25
Despite years of research, discussions and advocacy in relation to nurturing children's development through healthy eating and active living, there's been very little in the way of progress—sugary drinks are still advertised ...
Dec 5, 2022
0
19
The number of people who were dispensed opioid painkillers dropped during the height of Victoria's COVID-19 restrictions, then increased as lockdowns lifted, Monash University researchers have found.
Dec 5, 2022
0
0
Medication that helps reduce a person's risk of developing cardiovascular and kidney disease is a cost-effective option to treat Australia's entire population of people with type 2 diabetes, a new study has found.
Dec 1, 2022
0
45
